Local time:
A physician-founded consumer health company, built for inspection.
Evidence-backed formulations at clinically studied doses.
Transparent labels, traceable nutrients, independently verified.
HOFFRA / CONSUMER HEALTH
/The principles/
Four formulation rules. No exceptions.
The right ingredient. The right form. The right dose.
/001/
/Principle
Evidence first
Every ingredient and dose is selected from relevant human research. Trend, novelty and social-media popularity are not sufficient reasons for inclusion. Product decisions begin with evidence, not trend cycles or ingredient popularity.
/001/
/Principle
Evidence first
Every ingredient and dose is selected from relevant human research. Trend, novelty and social-media popularity are not sufficient reasons for inclusion. Product decisions begin with evidence, not trend cycles or ingredient popularity.
/001/
/Principle
Evidence first
Every ingredient and dose is selected from relevant human research. Trend, novelty and social-media popularity are not sufficient reasons for inclusion. Product decisions begin with evidence, not trend cycles or ingredient popularity.
/002/
/Principle
Full transparency
Declare real amounts. Avoid proprietary blends. Make the formula understandable enough that an informed customer can evaluate it independently. Every label should be readable and defensible.
/002/
/Principle
Full transparency
Declare real amounts. Avoid proprietary blends. Make the formula understandable enough that an informed customer can evaluate it independently. Every label should be readable and defensible.
/002/
/Principle
Full transparency
Declare real amounts. Avoid proprietary blends. Make the formula understandable enough that an informed customer can evaluate it independently. Every label should be readable and defensible.
/003/
/Principle
Bioavailable forms
Prefer forms selected for absorption, tolerability and biological relevance — appropriate chelates and active vitamers where justified. The form chosen should reflect the evidence, not manufacturing convenience.
/003/
/Principle
Bioavailable forms
Prefer forms selected for absorption, tolerability and biological relevance — appropriate chelates and active vitamers where justified. The form chosen should reflect the evidence, not manufacturing convenience.
/003/
/Principle
Bioavailable forms
Prefer forms selected for absorption, tolerability and biological relevance — appropriate chelates and active vitamers where justified. The form chosen should reflect the evidence, not manufacturing convenience.
/004/
/Principle
Considered restraint
Build a deliberately limited portfolio and finish each product properly. New formulations are admitted only when there is a clear physiological need or life-stage protocol that justifies a distinct product. Fewer products, better resolved.
/004/
/Principle
Considered restraint
Build a deliberately limited portfolio and finish each product properly. New formulations are admitted only when there is a clear physiological need or life-stage protocol that justifies a distinct product. Fewer products, better resolved.
/004/
/Principle
Considered restraint
Build a deliberately limited portfolio and finish each product properly. New formulations are admitted only when there is a clear physiological need or life-stage protocol that justifies a distinct product. Fewer products, better resolved.
HOFFRA
/Stay in the loop.
Evidence-led insights, never spam.
HOFFRA
/Stay in the loop.
Evidence-led insights, never spam.
HOFFRA
/Stay in the loop.
Evidence-led insights, never spam.
HOFFRA
/Stay in the loop.
Evidence-led insights, never spam.